Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.
Príomhchruthaitheoirí: | Phillips, A, Walker, A |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2004
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
de réir: Nicola Gianotti, et al.
Foilsithe / Cruthaithe: (2017-01-01) -
Timeliness of clinic attendance is a good predictor of virological response and resistance to antiretroviral drugs in HIV-infected patients.
de réir: Mathieu Bastard, et al.
Foilsithe / Cruthaithe: (2012-01-01) -
Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
de réir: Fidler, S, et al.
Foilsithe / Cruthaithe: (2002) -
Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
de réir: Fidler, S, et al.
Foilsithe / Cruthaithe: (2002) -
HIV multi‐drug resistance at first‐line antiretroviral failure and subsequent virological response in Asia
de réir: Awachana Jiamsakul, et al.
Foilsithe / Cruthaithe: (2014-01-01)